Skip to Content
Merck
All Photos(1)

Key Documents

View All Documentation

Safety Information

B3061

Sigma-Aldrich

Borrelidin

from Streptomyces parvulus, ≥98% (HPLC)

Synonym(s):

2-(7-Cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxooxacyclooctadeca-4,6-dien-2-yl)-cyclopentanecarboxylic acid, Borrelidine, Cyclopentanecarboxylic acid, NSC 216128, Treponemycin

Sign Into View Organizational & Contract Pricing

Select a Size

1 MG
¥82,900

¥82,900

Estimated to ship onJune 02, 2025

New, lower price on this item!
Request a Bulk Order
All Photos(1)

Select a Size

Change View
1 MG
¥82,900

About This Item

Empirical Formula (Hill Notation):
C28H43NO6
CAS Number:
7184-60-3
Molecular Weight:
489.64
MDL number:
MFCD01740784
UNSPSC Code:
12352200
PubChem Substance ID:
24724417
NACRES:
NA.77

¥82,900

Estimated to ship onJune 02, 2025

New, lower price on this item!
Request a Bulk Order

biological source

Streptomyces parvulus

Quality Level

200

Assay

≥98% (HPLC)

form

powder

solubility

DMSO: 1 mg/mL
methanol: 1 mg/mL

antibiotic activity spectrum

viruses

Mode of action

enzyme | inhibits

shipped in

wet ice

storage temp.

−20°C

SMILES string

[H][C@]1(CCC[C@H]1C(O)=O)[C@@H]2C\C=C\C=C(C#N)[C@H](O)[C@@H](C)C[C@H](C)C[C@H](C)C[C@H](C)[C@@H](O)CC(=O)O2

InChI

1S/C28H43NO6/c1-17-12-18(2)14-20(4)27(32)21(16-29)8-5-6-11-25(22-9-7-10-23(22)28(33)34)35-26(31)15-24(30)19(3)13-17/h5-6,8,17-20,22-25,27,30,32H,7,9-15H2,1-4H3,(H,33,34)/b6-5+,21-8-/t17-,18+,19-,20-,22+,23+,24-,25-,27+/m0/s1

InChI key

OJCKRNPLOZHAOU-UGKRXNSESA-N

Looking for similar products? Visit Product Comparison Guide

General description

Chemical structure: macrolide

Biochem/physiol Actions

Borrelidin is a potent angiogenesis inhibitor that induces apoptosis in capillary tube-forming cells. Also displays antimalarial activity against drug-resistant Plasmodia. Antimicrobial and selective threonyl t-RNA synthetase inhibitor.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

PDSCL

Deleterious substance

JAN Code

B3061-1MG:4548173228464
B3061-VAR:
B3061-BULK:
B3061-1MG-PW:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000380061
0000354271
0000380061
0000354271
0000097293

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Carlos Olano
The Journal of antibiotics, 64(1), 51-57 (2010-11-11)
Professor Charles Richard Hutchinson (Hutch) dedicated his research to the study of polyketide compounds, in particular, those produced by actinomycetes. Hutch principally centered his efforts to study the biosynthesis of bioactive compounds, antibiotic and antitumor drugs, and to develop new
András Jeney et al.
Magyar onkologia, 50(2), 93-100 (2006-08-05)
Further progress in the therapy of malignant diseases is expected from the introduction of potent antimetastatic drugs. Surveying of the complex and multi-step behavior of the metastatic process, compounds showing inhibitory action against tumor cell migration may be ranked among
Zhisheng Cao et al.
Bioscience, biotechnology, and biochemistry, 76(2), 353-357 (2012-02-09)
Streptomyces species strain GK18, isolated in Iran, induced deep-pitted lesions on potato tubers, lesions different from the raised lesions induced by the usual scab-causing phytotoxin, thaxtomin. In addition, neither thaxtomin production nor hybridization to its biosynthetic probe was detected for
Darya Habibi et al.
Investigational new drugs, 30(4), 1361-1370 (2011-06-17)
Due to the poor prognosis and limited therapeutic options for adult patients with acute lymphoblastic leukemia (ALL), development of novel therapies is much needed to prolong patient survival and increase the efficacy of their treatment. Malignant T cells need high
Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum.
Aki Ishiyama et al.
The Journal of antibiotics, 64(5), 381-384 (2011-02-24)
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service